September 5, 2017

Mitchell R. McGill, PhD

Mitch McGill
Assistant Professor


2017, Postdoctoral Fellowship, Washington University in St. Louis, Clinical chemistry and drug-induced liver disease
2013, PhD, University of Kansas, Toxicology
2007, BA, University of Missouri at Kansas City, Biology

Research Interests

  • Drug-induced liver injury
  • Biomarkers
  • Liver Regeneration
  • Clinical laboratory testing

Courses Taught

  • FDA Regulations (OEHM 6013)
  • Environmental Hazards Control (ENVH 5202)

Selected Recent Publications

Kennedy JL, Kurten RC, McCullough S, Panettieri RA Jr, Koziol-White C, Jones SM, Caid K, Gill PS, Roberts D, Jaeschke H, McGill MR, James L. Acetaminophen is both bronchodilatory and bronchoprotective in human precision cut lung slice airways. Xenobiotica. 2018;17:1-29.

McGill MR. The problem with predictive values: are we using the right metrics for preclinical prediction of drug hepatotoxicity? Toxicol Sci. 2018;165:3-4.

McGill MR, Jaeschke H. Biomarkers of drug-induced liver injury. Expert Rev Mol Diagn. 2018;18:797-807.

Lutkewitte AJ, Schweitzer GG, Kennon-McGill S, Clemens MM, James LP, Jaeschke H, Finck BN, McGill MR. Lipin deactivation after acetaminophen overdose causes phosphatidic acid accumulation in liver and plasma in mice and humans and enhances liver regeneration. Food Chem Toxicol. 2018;115:273-283.

Kennon-McGill S, McGill MR. Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms. J Clin Transl Res. 2018;3:5.